MedPath
HSA Approval

ROPIVACAINE B.BRAUN SOLUTION FOR INJECTION AND INFUSION 2MG/ML

SIN17164P

ROPIVACAINE B.BRAUN SOLUTION FOR INJECTION AND INFUSION 2MG/ML

ROPIVACAINE B.BRAUN SOLUTION FOR INJECTION AND INFUSION 2MG/ML

January 16, 2025

B. BRAUN SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantB. BRAUN SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

EPIDURAL, PERINEURAL

Medical Information

N01BB09

Manufacturer Information

B. Braun Singapore Pte Ltd.

B. Braun Medical S.A.

Active Ingredients

Ropivacaine hydrochloride

2mg/ml

Ropivacaine

Documents

Package Inserts

Package insert.pdf

Approved: January 16, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ROPIVACAINE B.BRAUN SOLUTION FOR INJECTION AND INFUSION 2MG/ML - HSA Approval | MedPath